|
Triumvirate Industries Case Study
Triumvirate
Industries, Inc., an international small
aircraft engine manufacturing firm, is in its
third generation of Barkley ownership.
Currently, there are forty shareholders in the
Company, some of which are trusts set up for the
benefit of members of the youngest generation.
Currently, there are ten members of the Barkley
family that are involved with the executive
management or Board of Directors of the
Company. The positions held by the members of
the family are as follows:
·
R.M. Barkley II, Chairman of the Board
·
R.M. Barkley III, CEO
·
Peter Barkley, CFO
·
William Barkley, Board Member
·
Jacqueline Barkley Smith, Board Member
·
Claudia Barkley Anderson, Board Member
·
Michael Barkley, Board Member
·
Jerry Barkley, Board Member
·
Alison Barkley Williams, Board Member
·
Christian Barkley Johanssen, Executive Vice
President International Operations
Though the
Company has run smoothly during the last decade,
the executive management and the Board of
Directors have run the Company with little
transparency and as little disclosure as
possible to the other shareholders. In the last
two years, the executive management at the
leisure of the Board has embarked on a largely
unsuccessful expansion into international
commercial aircraft financing. As a result of
the losses in the financing arm stemming from
the downturn in the global aviation industry,
Triumvirate Industries’ earnings remained flat,
showing no growth in net income or cash flow,
forcing the Board to suspend any increases in
the Company’s dividend—the first such suspension
of dividend increases in over fifty years.
Several members of the third and fourth
generation of the Barkley family have requested
additional information be disclosed regarding
the Company’s expansion into aircraft financing
and the Company’s overall financial position.
The executive management and the Board of
Directors have refused to disclose any
information other than that included with the
annual audited financial statements. The
Company’s annual report that was once considered
comprehensive and comparable to those published
by publicly traded companies has been suspended
by the executive management. These actions by
the executive management and the Board of
Directors come despite the recent revelations of
corporate malfeasance at companies such as
Adelphia, Enron, WorldCom, Tyco, etc.
As a result of
the brewing dissention between the executive
management and the Board of Directors and
certain shareholders, the group of dissenting
shareholders have filed suit against the Company
demanding more information and have waged a
proxy war to remove the Board and the executive
management. At the most recent shareholders’
meeting, the dissenting shareholders withheld
their still minority vote of roughly 30% of the
shares for the re-election of several Board
members. In response, the CEO replaced several
additional executive management personnel with
insiders friendly to the executive management
and the Board of Directors and willing to
support their agenda.
From a
valuation perspective, this dissention between
the shareholders and the executive management
will likely decrease the value of the firm by
increasing the Company’s cost of equity
capital. With favorable goodwill between the
executive management and the shareholders, the
Company’s “patient capital”
is likely lower than when relations between the
management and the shareholders are
acrimonious. In these situations, the
shareholders demand a higher return on their
invested capital in the firm. To appease the
shareholders, the executive management is faced
with the dilemma of protracted conflict, and
quite possibly litigation, or acquiescing to the
demands of the shareholders for a higher
return. This may prompt management to take
extraordinarily high risks that are needed to
generate the returns sufficient to satisfy the
shareholders’ demands for increased return on
capital, especially in the short term.
In
the case of Triumvirate Industries, assume that
the cost of equity capital using a build-up
method was previously estimated at 26%. The
Family Business Risk Premium factor analysis,
developed by Highland Global, LLC, was
originally estimated at 0.0%. As a result of
the dissention between the shareholders and the
executive management, the financial analyst
reassesses the Family Business Risk Premium
factor analysis. The ratings have changed
significantly based on the recent developments
at the Company, resulting in the following
factor analysis.
|
TABLE 1 |
|
|
|
|
Family
Business Attributes Risk Analysis |
|
|
|
|
Factor |
|
|
Rating |
|
|
|
|
|
|
|
1 |
Vision |
|
|
0.0 |
|
|
0 |
Clear,
developed vision |
|
|
|
|
1 |
Ambiguous or no vision |
|
|
|
|
|
|
|
|
|
2 |
Professionalization of Management Team |
|
1.0 |
|
|
0 |
Includes
outside professionals & advisors |
|
|
|
|
1 |
Primarily owners/insiders |
|
|
|
|
|
|
|
|
|
3 |
Professionalization of Ownership |
|
1.0 |
|
|
0 |
Regular
family meetings |
|
|
|
|
1 |
Irregular meetings, no long-term
ownership plans |
|
|
|
|
|
|
|
|
|
4 |
Effective Communication |
|
1.0 |
|
|
0 |
Clear
communication including annual reports |
|
|
|
|
1 |
No
effective communication between board &
owners |
|
|
|
|
|
|
|
|
|
5 |
Corporate Governance |
|
1.0 |
|
|
0 |
Transparent governance |
|
|
|
|
1 |
Opaque
governance |
|
|
|
|
|
|
|
|
|
6 |
Succession Plan |
|
1.0 |
|
|
0 |
Buy-sell
agreements in place |
|
|
|
|
1 |
No
effective succession plan in place |
|
|
|
|
|
|
|
|
|
7 |
Strategic Plan |
|
0.0 |
|
|
0 |
Strong
stragtegic plan in place &
accountability |
|
|
|
|
1 |
Weak
strategic plan and little accountability |
|
|
|
|
|
|
|
|
|
INDICATED FAMILY BUSINESS RISK PREMIUM |
5.0 |
Based on the
above the factor analysis, the cost of equity
capital (now demand capital) was estimated at
31% by the financial analyst. The increase from
the original patient capital stems from the
higher Family Business Risk Premium calculation,
as illustrated in the following table.
|
TABLE 2 |
|
|
|
Triumvirate Industries |
|
|
|
Cost
of Equity Capital Calculation |
Patient |
Demand |
|
Premia |
Capital |
Capital |
|
Risk
Free Rate |
5.0% |
5.0% |
|
Equity Risk Premium |
7.2% |
7.2% |
|
Size
Premium |
9.2% |
9.2% |
|
Specific Company Risk Premium |
4.6% |
4.6% |
|
Family Business Risk Premium |
0.0% |
5.0% |
|
Cost
of Equity Capital
|
26.0% |
31.0% |
Based on an assumed net cash flow to invested
capital of $3,000,000, the Company’s weighted
average cost of capital is estimated at 23.2%.
With the increased cost of equity capital and
the same net cash flow to invested capital of
$3,000,000 (assumed interest rate on debt of 8%
and tax rate of 35%), the Company’s weighted
average cost of capital increases to 26.9%.
With a long-term sustainable growth rate of 3%,
the capitalization rate with patient capital was
20.2% (multiple of 4.95) whereas the
capitalization rate resulting from the increased
demand capital is 23.9% (multiple of 4.18). As
a result of the increased demand capital, the
value of the firm and the value of its equity
decrease as illustrated in the following table.
|
TABLE 3 |
|
|
|
Triumvirate Industries |
|
|
|
Fair
Market Value of Firm |
Patient |
Demand |
|
|
Capital |
Capital |
|
Net
Cash Flow to Invested Capital |
$3,000,000 |
$3,000,000 |
|
Capitalization Rate |
20.2% |
23.9% |
|
Value of Invested Capital |
$14,851,485 |
$12,552,301 |
|
Less
Long-term Debt |
$2,000,000 |
$2,000,000 |
|
Value of Equity |
$12,851,485 |
$10,552,301 |
|
Less
Marketability Discount of 25% |
($3,212,871) |
($2,638,075) |
|
Fair
Market Value of Equity (rounded) |
$9,639,000 |
$7,914,000 |
|
Shares Outstanding |
2,000,000 |
2,000,000 |
|
Fair
Market Value per Share |
$4.82 |
$3.96 |
Based on the preceding example, the per share
value of the stock in Triumvirate Industries
decreased by roughly 18% as a result of the
increased demand capital stemming from the
deterioration in relations between the
management of the Company and some of its
shareholders. This should illustrate why it is
crucial for closely held or family controlled
businesses to excel in the seven attributes of
businesses that have been successful in creating
transgenerational wealth, as discussed in
Highland Global’s book The Seven Deadly Sins
of Business Valuation: Closely Held and Family
Controlled Companies, in order to maximize
wealth creation for shareholders.
|